NCT03193138View on ClinicalTrials.gov

CardioTOxicity Induced by andRogeNICS and Their Antagonists (TORNICS)

CompletedOBSERVATIONAL
Enrollment

3,096

Participants

Timeline

Start Date

June 7, 2017

Primary Completion Date

June 21, 2017

Study Completion Date

June 21, 2017

Conditions
Heart Diseases
Interventions
DRUG

Hormonal therapies: G03, H01C and L02 in the ATC classification

Hormonal therapies including all therapies classified G03, H01C and L02 in the ATC classification

Trial Locations (1)

75013

Centre Régional de Pharmaco-vigilance - Paris, Pitié-Salpétrière, Paris

All Listed Sponsors
lead

Groupe Hospitalier Pitie-Salpetriere

OTHER

NCT03193138 - CardioTOxicity Induced by andRogeNICS and Their Antagonists (TORNICS) | Biotech Hunter | Biotech Hunter